COVERSYL

This brand name is authorized in Nigeria. It is also authorized in Australia, Brazil, Cyprus, Ecuador, Finland, France, Ireland, Italy, Japan, Malta, Mexico, Netherlands, New Zealand, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug COVERSYL contains one active pharmaceutical ingredient (API):

1	Perindopril UNII TFT5IM1KGB - PERINDOPRIL ARGININE
	Perindopril is an inhibitor of the enzyme that converts angiotensin I into angiotensin II (Angiotensin Converting Enzyme ACE). The converting enzyme, or kinase, is an exopeptidase that allows conversion of angiotensin I into the vasoconstrictor angiotensin II as well as causing the degradation of the vasodilator bradykinin into an inactive heptapeptide. Inhibition of ACE results in a reduction of angiotensin II in the plasma, which leads to increased plasma renin activity (by inhibition of the negative feedback of renin release) and reduced secretion of aldosterone. Since ACE inactivates bradykinin, inhibition of ACE also results in an increased activity of circulating and local kallikrein-kinin systems (and thus also activation of the prostaglandin system).
	Read more about Perindopril

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-5001	Tablet	Coversyl 5 mg Tablets TAB 5 mg 1 x 15's; 1 x 30's	Film-coated tablet. Light-green, rod-shaped film-coated tablet engraved with symbol on both edges. The tablet can be divided into equal doses	28/09/2021
A4-5030	Tablet	COVERSYL TABLET TAB 10 mg 1 X15	COVERSYL TABLET COVERSYL PERINDOPRIL ARGININE 10MG POM TABLET 1 X15 ANTIHYPERTENSIVE CHI PHARMACEUTICAL LIMITED 14, CHIVITA AVENUE, AJAO EST LAGOS SERVIER (IRELAND) INDUSTRIES LIMITED GOREY ROAD, ARKLOW CO. WICKLOW, IRELAND GMP- SATIS; LR- SATIS; FEES- PAID; NP:NA 18/12/2015 A4-5030	30/01/2020

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
COVERSYL ARGININE Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09AA04	Perindopril	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	9006B, 9007C, 9008D
BR	Câmara de Regulação do Mercado de Medicamentos	531300302111316, 531300303116419
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28796-03-09, 28830-04-09
ES	Centro de información online de medicamentos de la AEMPS	58636
FI	Lääkealan turvallisuus- ja kehittämiskeskus	020918, 020940, 020992, 021033
FR	Base de données publique des médicaments	63849839, 68391071, 69475939
GB	Medicines & Healthcare Products Regulatory Agency	134444, 134447, 134450, 134453, 142096, 161540, 161606, 175367, 182258, 185712, 185714, 187434, 197210
IE	Health Products Regulatory Authority	18428, 18481, 19407, 19433, 19441, 19492
IT	Agenzia del Farmaco	027286210, 027286323, 044382012, 044382024, 044382036, 044382048, 047260017, 047260043
JP	医薬品医療機器総合機構	2144012F1028, 2144012F2024
MT	Medicines Authority	MA066/00401, MA066/00403, MA066/00404, MA066/01501, PI1438/04901A, PI1438/04902A, PI1438/04903A, PI770/09901A, PI770/09902A, PI770/09903A, PI908/00502A, PI908/00503A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	485M94
NG	Registered Drug Product Database	A4-5001, A4-5030
NL	Z-Index G-Standaard, PRK	85154, 85162, 85170
NZ	Medicines and Medical Devices Safety Authority	10983, 22125, 22126, 22996
SG	Health Sciences Authority	04548P, 13040P, 13494P, 13495P, 14183P, 14184P, 14185P
TN	Direction de la Pharmacie et du Médicament	6353012, 6353151, 6353152, 6353153
TR	İlaç ve Tıbbi Cihaz Kurumu	8699552090458, 8699552090465, 8699552090892
ZA	Health Products Regulatory Authority	38/7.1.3/0119, A39/7.1.3/0235, A39/7.1.3/0236, X/7.1.3/314